Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-07-05, Stock:NVS, The news for the past five days is as follows:
2018-06-27: NEWS1: The Swiss Stock Market Recovered From Early Weakness.NEWS2: The Swiss Stock Market Recovered From Early Weakness.
2018-06-28: NEWS1: Piper Jaffray, Stifel Defend Array Biopharma As Stock Falls On Profit-Taking.NEWS2: The Swiss Stock Market Pulled Back Along With The Rest Of Europe.NEWS3: The Swiss Stock Market Pulled Back Along With The Rest Of Europe.NEWS4: Majority Of Workers With Migraine Miss A Week Of Work Per Month: Novartis Study.NEWS5: Majority Of Workers With Migraine Miss A Week Of Work Per Month: Novartis Study.
2018-06-29: NEWS1: [$$] Novartis to Spin Off Alcon Eye-Care Business.NEWS2: Sanofi (SNY) Finalizes Deal for European Generic Unit Sale.NEWS3: Sanofi (SNY) Finalizes Deal for European Generic Unit Sale.NEWS4: Lilly's (LLY) Taltz Positive in Ankylosing Spondylitis Study.NEWS5: Lilly's (LLY) Taltz Positive in Ankylosing Spondylitis Study.NEWS6: Novartis Stock Pops on Alcon Spinoff News.NEWS7: Novartis Stock Pops on Alcon Spinoff News.NEWS8: Novartis Surges On Decision To Spin Off Alcon Eye Devices Unit.NEWS9: Stocks Stumble at Friday's Close, Giving Up Most of Day's Gains.NEWS10: Stocks Trim Gains Heading Into Final Hour of Trading.NEWS11: Health Care Sector Update for 06/29/2018: NVS,GSK,GEMP,TMO,ROP,APEN.NEWS12: Health Care Sector Update for 06/29/2018: NVS,GSK,GEMP,TMO,ROP,APEN.NEWS13: Stocks Rise as Big Banks Move Higher, Dow Jumps as Nike Soars.NEWS14: UPDATE 1-Rival Novartis, Gilead CAR-T therapies win European panel recommendation.NEWS15: Novartis Stock Pops on Alcon Spinoff News.NEWS16: Nike soars, Novartis jumps, Deutsche Bank on the rise.NEWS17: Novartis Holding On To Strong Gain After Initial Jump.NEWS18: Novartis Holding On To Strong Gain After Initial Jump.NEWS19: Novartis hands investors Alcon spin-off, $5 billion share buyback.NEWS20: Nike’s stock leaps on earnings report, Novartis spins off Alcon, Fox sets date for Disney vote.NEWS21: European ADRs Move Higher in Friday Trading.NEWS22: European ADRs Move Higher in Friday Trading.NEWS23: Nike, Novartis and Deutsche Bank are the Yahoo Finance charts of the day.NEWS24: Novartis Is Spinning Off Its Alcon Eye Care Business and Launching a $5 Billion Share Buyback.NEWS25: Nike’s stock leaps on earnings report, Novartis spins off Alcon, Fox sets date for Disney vote.NEWS26: Interested In Pharmaceutical Stocks? Try Novartis (ADR).NEWS27: Novartis Doesn't Appear Ready to Make Healthy Move Higher.NEWS28: Ron Squarer&apos;s risk-taking pays off at Array.NEWS29: Rival Novartis, Gilead CAR-T therapies win European panel recommendation.NEWS30: The Swiss Stock Market Climbed On Novartis Strength.NEWS31: The Swiss Stock Market Climbed On Novartis Strength.NEWS32: Benzinga's Daily Biotech Pulse: Gemphire On Fire, Acceleron-Celgene Taste Success, AbbVie Ditches Galapagos.NEWS33: Stocks making the biggest moves in the premarket: STZ, WFC, BAC, JPM, C, NKE & more.NEWS34: European Markets Climbed After Migration Deal Reached.NEWS35: European Markets Climbed After Migration Deal Reached.NEWS36: Nike, Deutsche Bank, Goldman Sachs and Novartis - 5 Things You Must Know.NEWS37: Novartis Goes Back to Its $191 Billion Core.NEWS38: Novartis hands investors Alcon spin-off and $5 billion share buyback.NEWS39: Novartis to Spin Off Eye-Care Unit, Buy Back $5B in Shares.NEWS40: [$$] European Stocks Market Talk Roundup.NEWS41: Novartis Gets Positive CHMP Opinion For Kymriah To Treat Two Blood Cancers.NEWS42: Novartis Gets Positive CHMP Opinion For Kymriah To Treat Two Blood Cancers.NEWS43: Novartis hands investors Alcon spin-off and $5 billion share buyback.NEWS44: [$$] Novartis Announces Buyback, Eye-Care Spinoff.NEWS45: European Shares Rally On EU Migration Deal.NEWS46: European Shares Rally On EU Migration Deal.NEWS47: [$$] Novartis slims down with $25bn spin-off of Alcon eyecare business.NEWS48: [$$] Novartis to spin off Alcon, announces $5bn buyback.NEWS49: Novartis to Spin Off Alcon as CEO Focuses on Finding Drugs.NEWS50: Novartis to Spin Off Alcon, Plans $5 Billion Share Buyback.NEWS51: [$$] Novartis: one in the eye.NEWS52: Novartis To Spin Off Alcon, Buy Back Up To $5 Bln Of Shares.NEWS53: Novartis To Spin Off Alcon, Buy Back Up To $5 Bln Of Shares.
2018-07-02: NEWS1: [$$] Novartis Injects Itself Into Planned Rollout of EpiPen Competitor.NEWS2: Novartis to Spin-Off Alcon as Separate Trading Company.NEWS3: Novartis to Spin-Off Alcon as Separate Trading Company.NEWS4: ADMP Abuzz, MESO Has A Blast, COOL Rebounds, BLFS Up Nearly 150% YTD.NEWS5: ADMP Abuzz, MESO Has A Blast, COOL Rebounds, BLFS Up Nearly 150% YTD.NEWS6: Novartis to Spin-Off Alcon as Separate Trading Company.NEWS7: Health Care Sector Update for 07/02/2018: ABBV,PRGO,TEVA,NVS,ADMP,MRK,AZN.NEWS8: Health Care Sector Update for 07/02/2018: ABBV,PRGO,TEVA,NVS,ADMP,MRK,AZN.NEWS9: Novartis Securities Investment Ltd -- Moody's downgrades Novartis' rating to A1; stable outlook.NEWS10: Adamis Pharma Shares Soar on Deal With Novartis for Epipen Competitor.NEWS11: Nordstrom may have trouble, Novartis signs distribution deal, Netflix buys LA billboards.NEWS12: Gilead's (GILD) CAR T Therapy Gets Positive CHMP Opinion.NEWS13: Gilead's (GILD) CAR T Therapy Gets Positive CHMP Opinion.NEWS14: After a year-long search, Adamis has a partner to market its EpiPen competitor.NEWS15: Nordstrom may have trouble according to analyst, Novartis signs distribution deal for EpiPen competitor, Netflix reportedly buys LA billboards.NEWS16: The Swiss Stock Market Pulled Back On Trade War Concerns.NEWS17: The Swiss Stock Market Pulled Back On Trade War Concerns.
2018-07-03: NEWS1: Adamis (ADMP) Surges Following Novartis Deal for Symjepi.NEWS2: Adamis (ADMP) Surges Following Novartis Deal for Symjepi.NEWS3: GlaxoSmithKline’s Valuation on June 29.NEWS4: Adamis (ADMP) Surges Following Novartis Deal for Symjepi.NEWS5: The Swiss Stock Markets Climbed On Strength Of Defensive Heavyweights.NEWS6: The Swiss Stock Markets Climbed On Strength Of Defensive Heavyweights.NEWS7: Adamis has a partner to market its EpiPen competitor after a year-long search.

Answer: Rise